Evidence map›Paper›PMID 26082896›Full record

ReviewFrontiers in cellular and infection microbiology2015

Purification and proteomics of pathogen-modified vacuoles and membranes.

Jo-Ana Herweg, Nicole Hansmeier, Andreas Otto, Anna C Geffken, Prema Subbarayal, Bhupesh K Prusty, Dörte Becher, Michael Hensel, Ulrich E Schaible, Thomas Rudel and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Bacterial Puppeteering: How the Stealth BacteriumPathogens (Basel, Switzerland) · 2025
    Review
  2. Microorganisms · 2024
    Article
  3. Article
  4. Biochemically Reconstituted Fusion of Phagosomes with Endosomes and Lysosomes.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  5. Proteome analysis ofFrontiers in cellular and infection microbiology · 2022
    Article
  6. Article
  7. Review
  8. Proteomic Analysis ofMolecular & cellular proteomics : MCP · 2020
    Article
  9. Review
  10. Article
  11. Chlamydial Infection From Outside to Inside.Frontiers in microbiology · 2019
    Review
  12. Review
  13. Article
  14. Peptidase Inhibitor 15 (PI15) Regulates Chlamydial CPAF Activity.Frontiers in cellular and infection microbiology · 2018
    Article
  15. Proteomics ofFrontiers in immunology · 2018
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Formation of theFrontiers in cellular and infection microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Jo-Ana HerwegChair of Microbiology, Biocenter, University of Würzburg Würzburg, Germany.
Nicole HansmeierDivision of Microbiology, University of Osnabrück Osnabrück, Germany.
Andreas OttoInstitute of Microbiology, Ernst-Moritz-Arndt University Greifswald Greifswald, Germany.
Anna C GeffkenPriority Area Infections, Cellular Microbiology, Research Center Borstel, Leibniz Center for Medicine and Biosciences Borstel, Germany.
Prema SubbarayalChair of Microbiology, Biocenter, University of Würzburg Würzburg, Germany.
Bhupesh K PrustyChair of Microbiology, Biocenter, University of Würzburg Würzburg, Germany.
Dörte BecherInstitute of Microbiology, Ernst-Moritz-Arndt University Greifswald Greifswald, Germany.
Michael HenselDivision of Microbiology, University of Osnabrück Osnabrück, Germany.
Ulrich E SchaiblePriority Area Infections, Cellular Microbiology, Research Center Borstel, Leibniz Center for Medicine and Biosciences Borstel, Germany.
Thomas RudelChair of Microbiology, Biocenter, University of Würzburg Würzburg, Germany.
Hubert HilbiDepartment of Medicine, Max von Pettenkofer Institute, Ludwig-Maximilians University Munich Munich, Germany ; Department of Medicine, Institute of Medical Microbiology, University of Zürich Zürich, Switzerland.
University of Würzburg · DEOsnabrück University · DEResearch Center Borstel - Leibniz Lung Center · DEUniversität Greifswald · DEUniversity of Zurich · CH

Funding

Medical Research Council G0700163
6 · The paper itself

Abstract

Certain pathogenic bacteria adopt an intracellular lifestyle and proliferate in eukaryotic host cells. The intracellular niche protects the bacteria from cellular and humoral components of the mammalian immune system, and at the same time, allows the bacteria to gain access to otherwise restricted nutrient sources. Yet, intracellular protection and access to nutrients comes with a price, i.e., the bacteria need to overcome cell-autonomous defense mechanisms, such as the bactericidal endocytic pathway. While a few bacteria rupture the early phagosome and escape into the host cytoplasm, most intracellular pathogens form a distinct, degradation-resistant and replication-permissive membranous compartment. Intracellular bacteria that form unique pathogen vacuoles include Legionella, Mycobacterium, Chlamydia, Simkania, and Salmonella species. In order to understand the formation of these pathogen niches on a global scale and in a comprehensive and quantitative manner, an inventory of compartment-associated host factors is required. To this end, the intact pathogen compartments need to be isolated, purified and biochemically characterized. Here, we review recent progress on the isolation and purification of pathogen-modified vacuoles and membranes, as well as their proteomic characterization by mass spectrometry and different validation approaches. These studies provide the basis for further investigations on the specific mechanisms of pathogen-driven compartment formation.

Indexed as

Bacterial Physiological PhenomenaHost-Pathogen InteractionsHumansIntracellular MembranesMass SpectrometryProteomeProteomicsVacuolesProteomeChlamydiahost-pathogen interactionsimmuno-magnetic purificationLegionellaMycobacteriumpathogen vacuoleSalmonellaSimkania

Identifiers

PMID26082896
PMCPMC4451638
OpenAlexW1577902001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.